logo

AstraZeneca halts COVID-19 vaccine trial for safety review

A major vaccine trial by British-Swedish drugmaker AstraZeneca was halted due to a serious adverse reaction by a participant in the trials. The company plans to have a safety review and minimise the impact on the trial timeline. Meanwhile, the World Health Organisation has started a review of the international health response strategy to the COVID-19 pandemic on Tuesday. Dr Francis Ohanyido, President of the West Africa Academy of Public Health joins CNBC Africa for more.


Wed Sep 09 2020 | 08:47:40 GMT+0000 (Coordinated Universal Time)

Share

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.